bioAffinity Technologies, Inc. (BIAF)
NCM – Real vaqt narxi. Valyuta: USD
1.88
-0.09 (-4.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.95
+0.07 (3.81%)
Bozor oldidan: May 13, 2026, 5:25 AM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
1.88
-0.09 (-4.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.95
+0.07 (3.81%)
Bozor oldidan: May 13, 2026, 5:25 AM EDT
bioAffinity Technologies, Inc. Qo'shma Shtatlarda oqim sitometriyasi va avtomatlashtirilgan tahlil yordamida erta bosqichdagi o'pka rakini va boshqa o'pka kasalliklarini aniqlash uchun invaziv bo'lmagan diagnostik laboratoriya testlarini ishlab chiqish bilan shug'ullanadi. Kompaniya ikkita segment orqali faoliyat yuritadi: Diagnostik tadqiqot va ishlanmalar; va Laboratoriya xizmatlari. Kompaniya CyPath lungni taklif etadi, u insonning balg'amidagi hujayra populyatsiyalarini aniqlash va tahlil qilish uchun oqim sitometriyasi texnologiyasidan foydalanadi, bu o'pka rakiga ishora qiluvchi belgilar, shu jumladan o'pka o'smadan ajralib chiqqan rak va/yoki rak bilan bog'liq hujayralarni topish uchun. Kompaniya astma va surunkali obstruktiv o'pka kasalliklari uchun yallig'lanish biomarkerlarini aniqlash bo'yicha ishlab chiqilayotgan o'ziga xos testlarini baholash uchun Brooke Army Medical Center bilan hamkorlik qiladi. bioAffinity Technologies, Inc. 2014 yilda tashkil etilgan va San Antonio, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Gordon Downie M.D., Ph.D. | Chief Medical Officer |
| Dr. William Bauta Ph.D. | Chief Science Officer |
| Mr. Dallas J. Coleman | Vice President of sales |
| Mr. James Michael Edwards C.P.A., M.B.A. | Chief Financial Officer |
| Mr. Steven Girgenti | Founder & Executive Chairman of the Board |
| Mr. Timothy P. Zannes J.D. | Executive VP, Secretary & General Counsel |
| Mr. Xavier T. Reveles M.S. | Chief Operating Officer |
| Ms. Julie Anne Overton | Director of Communications |
| Ms. Maria Zannes J.D. | Founder, President, CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 8-K | form8-k.htm |
| 2026-04-30 | S-1 | forms-1.htm |
| 2026-04-14 | 8-K | form8-k.htm |
| 2026-04-07 | 8-K | form8-k.htm |
| 2026-04-01 | 8-K | form8-k.htm |
| 2026-03-26 | 8-K | form8-k.htm |
| 2026-03-25 | 8-K | form8-k.htm |
| 2026-03-17 | 8-K | form8-k.htm |
| 2026-03-16 | ARS | formars.pdf |
| 2026-03-13 | 8-K | form8-k.htm |